GC
MDXG icon

Gratus Capital’s MiMedx Group MDXG Stock Holding History

Gratus Capital’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,525
Closed -$66.6K – 250
2023
Q1 		$66.6K Hold
19,525
– – 0.01% 220
2022
Q4 		$54.3K Hold
19,525
– – ﹤0.01% 224
2022
Q3 		$56K Hold
19,525
– – 0.01% 199
2022
Q2 		$68K Hold
19,525
– – 0.01% 190
2022
Q1 		$92K Hold
19,525
– – 0.01% 199
2021
Q4 		$118K Sell
19,525
-14,225
-42% -$98.8K 0.01% 200
2021
Q3 		$205K Hold
33,750
– – 0.02% 181
2021
Q2 		$422K Hold
33,750
– – 0.05% 144
2021
Q1 		$348K Buy
+33,750
New +$326K 0.04% 151

Other funds holding MDXG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gratus Capital's MDXG Position: Q2 2023 in Review

Gratus Capital sold out of MiMedx Group (MDXG) in Q2 2023, closing a stake of 19,525 shares — an estimated $66.6K sold.

Gratus Capital first reported a position in MDXG in Q1 2021 and held it in 9 quarters. The position peaked at $422K in Q2 2021. 177 funds tracked by Wall St. Rank hold MDXG as of Q2 2023.

  • Gratus Capital reported no remaining MiMedx Group position as of Q2 2023 after selling out during the quarter.
  • Gratus Capital sold 19,525 MiMedx Group shares in Q2 2023, an estimated $66.6K.
  • Gratus Capital first reported a position in MiMedx Group in Q1 2021 and held it in 9 quarters.
  • Gratus Capital's MiMedx Group position peaked at $422K in Q2 2021.
  • 177 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2023.

Based on Gratus Capital's 13F filing for Q2 2023, filed 3 Aug 2023.